1. Home
  2. ELTX vs CBFV Comparison

ELTX vs CBFV Comparison

Compare ELTX & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • CBFV
  • Stock Information
  • Founded
  • ELTX 2011
  • CBFV 1901
  • Country
  • ELTX United States
  • CBFV United States
  • Employees
  • ELTX N/A
  • CBFV N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • CBFV Major Banks
  • Sector
  • ELTX Health Care
  • CBFV Finance
  • Exchange
  • ELTX Nasdaq
  • CBFV Nasdaq
  • Market Cap
  • ELTX 121.7M
  • CBFV 140.0M
  • IPO Year
  • ELTX N/A
  • CBFV N/A
  • Fundamental
  • Price
  • ELTX $8.09
  • CBFV $28.65
  • Analyst Decision
  • ELTX Strong Buy
  • CBFV Hold
  • Analyst Count
  • ELTX 2
  • CBFV 2
  • Target Price
  • ELTX $9.50
  • CBFV $26.00
  • AVG Volume (30 Days)
  • ELTX 46.9K
  • CBFV 43.3K
  • Earning Date
  • ELTX 08-12-2025
  • CBFV 07-23-2025
  • Dividend Yield
  • ELTX N/A
  • CBFV 3.44%
  • EPS Growth
  • ELTX N/A
  • CBFV N/A
  • EPS
  • ELTX N/A
  • CBFV 1.92
  • Revenue
  • ELTX N/A
  • CBFV $49,545,000.00
  • Revenue This Year
  • ELTX N/A
  • CBFV $5.97
  • Revenue Next Year
  • ELTX N/A
  • CBFV $9.49
  • P/E Ratio
  • ELTX N/A
  • CBFV $14.89
  • Revenue Growth
  • ELTX N/A
  • CBFV N/A
  • 52 Week Low
  • ELTX $3.70
  • CBFV $22.16
  • 52 Week High
  • ELTX $9.99
  • CBFV $33.72
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 62.14
  • CBFV 57.50
  • Support Level
  • ELTX $7.76
  • CBFV $28.78
  • Resistance Level
  • ELTX $8.94
  • CBFV $29.43
  • Average True Range (ATR)
  • ELTX 0.37
  • CBFV 0.50
  • MACD
  • ELTX -0.03
  • CBFV 0.17
  • Stochastic Oscillator
  • ELTX 51.09
  • CBFV 83.19

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About CBFV CB Financial Services Inc.

CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.

Share on Social Networks: